Returning investors Agilent Technologies and Alexandria Venture Investments chipped into a $12.2m round for the DNA synthesis technology developer.

Immuno-oncology startup Stipe, based on Aarhus research, has secured $22m in a round co-led by Novo Seeds, after being incubated at Novo's BioInnovation Institute.

The UC Berkeley-founded gene therapy developer plans to use the IPO proceeds to advance treatments for Fabry disease, cystic fibrosis and ophthalmological diseases.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

CVC Capital Partners is in talks to pay $450m for a 25% stake in the Access Industries-backed app monetisation platform developer, with investors in line to receive dividends from the deal.

Stripe has returned for the digital payments technology provider's series C round, which valued it at nearly $1bn, with the proceeds to fund international growth.

OSF Healthcare and Wanxiang both returned for the extension having also contributed to a $45m first close for the patient management platform developer.

Alibaba is now the largest investor in property design software producer 3vjia following a $70m deal that comes after a Red Star Macalline-led series B round last year.

Tencent contributed to the first disclosed round for the finance management software provider following its participation in Sequoia India's Surge accelerator.

The medical research provider secured $32.7m in a round backed by existing investor Holtzbrinck Digital that will fund its entry into new markets.